Navigation Links
Kensey Nash Receives FDA 510(k) Clearance for Porcine Dermis Biologic Product
Date:11/11/2009

are committed to developing unique and effective therapies that address the unmet clinical needs of physicians and patients around the world," he concluded.

The Company had previously announced a strategic agreement with Synthes, Inc. (SWX:SYST.VX), whereby Synthes will market and distribute porcine dermis-based ECM products for select reconstructive surgical applications. Kensey Nash is currently evaluating partnering opportunities for additional applications of the Medeor Matrix products in the urogynecology, wound care, orthopaedic and other markets. The Company anticipates that Medeor Matrix will be introduced into the market for initial indications in the second half of the current fiscal year.

About Kensey Nash Corporation. Kensey Nash Corporation is a leader in developing, manufacturing and processing resorbable biomaterial products, incorporating its proprietary collagen and synthetic polymer technology. This expertise is used to develop and commercialize its products through strategic partners. The company has an extensive range of products, which are sold in multiple medical markets, including, the cardiology, orthopedic, sports medicine, spine, endovascular and general surgery markets. The company is known as a pioneer in the field of arterial puncture closure, as the inventor and developer of the Angio-Seal(TM) Vascular Closure Device, which is licensed to St. Jude Medical, Inc.

Cautionary Note for Forward-Looking Statements. This press release as well as other Company press releases contains forward-looking statements that reflect the Company's current expectations about its prospects and opportunities. The Company has tried to identify these forward looking statements by using words such as "expect," "anticipate," "estimate," "plan," "will," "would," "forecast," "believe," "guidance," "projection" or similar expressions, but these words are not the exclusive means for identifying such statements.
'/>"/>

SOURCE Kensey Nash Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Kensey Nash Announces IDE Submission for Cartilage Repair Device
2. Kensey Nash Announces Presentations on its Cartilage Repair Device at the International Cartilage Repair Society Meeting
3. Kensey Nash Corporation Announces Its First Quarter Fiscal Year 2010 Earnings Release Date and Teleconference
4. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
5. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
6. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
7. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
8. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
9. CryoCor Receives FDA Approval for Right Atrial Flutter
10. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
11. Dimericine(R) Receives FDA Fast Track Designation for Treatment Of Photosensitivity in XP Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... SEATTLE , June 3, 2015 ... acquire Northeast Pharmaceuticals, Inc., bringing together two pharmacy organizations ... with mental illness. Both companies have strong reputations for ... their customers. Genoa ... the behavioral health community and those affiliated with managing ...
(Date:6/3/2015)... , June 3, 2015 Creekridge Capital, ... of its sales channels by adding two new sales ... as a Regional Sales Manager and Stefanie Stark ... Mr. Puma comes to Creekridge with over 20 ... his role at Creekridge, Mr. Puma will be responsible ...
(Date:6/3/2015)...  Halozyme Therapeutics, Inc. (NASDAQ: HALO ) ... with AbbVie (NYSE: ABBV ) to develop and ... ENHANZE ™ platform. Under ... an initial $23 million payment, followed by milestone ... up to nine collaboration targets. These payments are ...
Breaking Medicine Technology:Genoa, a QoL Healthcare Company Acquires Northeast Pharmaceuticals, Inc. 2Creekridge Capital Strengthens Sales Team 2Halozyme Enters Into Global Collaboration and Licensing Agreement With AbbVie 2Halozyme Enters Into Global Collaboration and Licensing Agreement With AbbVie 3
... 3, 2011 Reportlinker.com announces that a new market ... Probiotics and Prebiotics in Clinical Nutrition ... Introduction Overall sales of clinical nutrition ... US and EU as well as rising incidence of ...
... May 3, 2011 Researchers from the University of ... American Roentgen Ray Society 2011 Annual Meeting ... and reduce radiation exposure for breast cancer patients.   ... systems that can show the location as well as ...
Cached Medicine Technology:Reportlinker Adds Probiotics and Prebiotics in Clinical Nutrition 2Reportlinker Adds Probiotics and Prebiotics in Clinical Nutrition 3Reportlinker Adds Probiotics and Prebiotics in Clinical Nutrition 4Study Shows Same Day PET-Guided Biopsy May Expedite Pre-Operative Work-up For Breast Cancer Patients and Reduce Radiation Exposure 2
(Date:6/3/2015)... Pittsburgh, Pa (PRWEB) June 03, 2015 EMBARGOED ... , Lower Birth Weight Associated with Proximity of Mother’s Home ... women living close to a high density of natural gas ... babies with lower birth weights than women living farther from ... School of Public Health analysis of southwestern Pennsylvania birth ...
(Date:6/3/2015)... 03, 2015 Johnson & Johnson and ... million to resolve a Risperdal lawsuit ( http://www.risperdallawsuit2014.com/ ) ... company allegedly used to market the antipsychotic drug. ... that the Arkansas Attorney General moved to dismiss the ... The Risperdal settlement amounts to just a fraction of ...
(Date:6/3/2015)... Follow us on LinkedIn – ... treatment on account of their better mode of action ... rheumatoid arthritis. The industry is expected to witness a ... drugs to biopharmaceuticals over the coming years. The high ... therapies, and recombinant proteins has attracted industry players to ...
(Date:6/3/2015)... June 03, 2015 Dr. Steven Reisman, a ... Diagnostic Center ( http://www.newyorkcardiac.com ) located in NYC, announced today ... to his practice. In most cases, depending on the level ... day they call, they will be seen by a cardiologist ... as a cardiologist is to ensure that people who have ...
(Date:6/3/2015)... (PRWEB) June 03, 2015 VeoMed ... to expand online and mobile access to premier ... and Maintenance of Certification (MOC) activities. ... VeoMed’s innovative courses to Decker’s extensive lists of ... in purchasing access to VeoMed’s premier online and ...
Breaking Medicine News(10 mins):Health News:Fracking Proximity Associated with Lower Birth Weight 2Health News:Fracking Proximity Associated with Lower Birth Weight 3Health News:Fracking Proximity Associated with Lower Birth Weight 4Health News:Risperdal Lawsuit News: Johnson & Johnson, Janssen Settle Arkansas Marketing Case for $7.8 Million 2Health News:Risperdal Lawsuit News: Johnson & Johnson, Janssen Settle Arkansas Marketing Case for $7.8 Million 3Health News:Risperdal Lawsuit News: Johnson & Johnson, Janssen Settle Arkansas Marketing Case for $7.8 Million 4Health News:Superior Efficacy of Biopharmaceuticals Against Chronic Diseases Drives the Global Biopharmaceuticals Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Superior Efficacy of Biopharmaceuticals Against Chronic Diseases Drives the Global Biopharmaceuticals Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:Superior Efficacy of Biopharmaceuticals Against Chronic Diseases Drives the Global Biopharmaceuticals Market, According to a New Report by Global Industry Analysts, Inc. 4Health News:NYC Cardiologist, Dr. Steven Reisman, Announces Same Day and Evening Appointments 2Health News:VeoMed and Decker Intellectual Properties, the Owner of Scientific American Medicine, Announce a Partnership to Expand Access to Premier Online CME Courses 2
... be especially diligent about having routine screening colonoscopies, results ... at Buffalo indicate. , Their findings show that persons ... polyps, known as adenomas, and advanced adenomas than men ... were presented Oct. 19 at a 10:30 a.m. session ...
... Dogs may not only be man,s best friend, they ... children with special needs. According to a new Universit de ... anxiety and enhance the socialization skills of children with Autism ... Psychoneuroendocrinology may be a relatively simple solution to help ...
... is not a foreign sight. But what about a turtle or ... fact, according to Gordon Burghardt, a psychology professor at the University ... monkeys -- need a little play time. "I studied ... never saw anything that I thought was play. Then I had ...
... SEATTLE, Wash.October 18, 2010Researchers at the Allen Institute for ... different activity patterns in the brain in individuals with ... individual differences in the effectiveness and side-effect profiles of ... The study is available in this week,s online early ...
... Oct. 19 (HealthDay News) -- People with depression and ... undergoing surgery, a new study suggests. U.S. researchers ... care units between Oct. 1, 2003 and Sept. 30, ... existing psychiatric condition, including 5,500 (15.5 percent) with depression, ...
... , MONDAY, Oct. 18 (HealthDay News) -- Invasive dental procedures ... heart attack and stroke, researchers say. But the increase ... "I don,t want to downplay this entirely, because we ... just after dental work was done among patients undergoing invasive ...
Cached Medicine News:Health News:Prostate cancer patients are at increased risk of precancerous colon polyps 2Health News:Children's best friend 2Health News:UT professor defines play, discovers even turtles need recess 2Health News:Gene activity in the brain depends on genetic background 2Health News:Depression, Anxiety May Raise Surgery Risks 2Health News:Invasive Dentistry May Raise Short-Term Heart, Stroke Risk 2Health News:Invasive Dentistry May Raise Short-Term Heart, Stroke Risk 3
... on-the-spot reference guide for ... On the wards, in ... or at the bedside, ... access to reliable, clinically ...
This easy-to-navigate reference provides clear, current, clinically proven recommendations for diagnosis and treatment of neurologic disorders....
... enable all those involved with healthcare decisions ... very latest evidence in their field of ... each year as the volume of evidence ... delivering the best single source available for ...
Treatment Strategies in Cardiovascular Medicine...
Medicine Products: